ARBUCKLE STUART A (EVP\Chief Commercial Officer) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 7/2/2025ACC: 0000875320-25-000204
Officer· EVP\Chief Commercial Officer
Since Jun 2018
-37.24K
Net shares
Net seller
$16.77M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
37.24K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−37.24K
Price / share
$450.23
Trade value
$16.77M
% of position
37.0%
7/1/2025
100.61K→63.37K
Total
Net shares
−37.24K
Net value
-$16.77M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2025 | F · Tax Withholding | −37.24K | $450.23 | $16.77M | 37.0% | 100.61K | 63.37K |
| Total | −37.24K | -$16.77M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned140.00
Total
140.00 indirect140.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 140.00 | Indirect |
| Total | 140.00 | 140.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported